Adlai Nortye Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment. The company was founded on May 9, 2018, and is headquartered in Hangzhou, China.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
123
Frequently Asked Questions
What is Market Cap of Adlai Nortye Ltd. - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Adlai Nortye Ltd. - ADR market cap is $55.91M.
What is the 52-week high for Adlai Nortye Ltd. - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Adlai Nortye Ltd. - ADR 52 week high is $3.89 as of September 18, 2025.
What is the 52-week low for Adlai Nortye Ltd. - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Adlai Nortye Ltd. - ADR 52 week low is $1.10 as of September 18, 2025.
What is Adlai Nortye Ltd. - ADR stock price today?
Adlai Nortye Ltd. - ADR stock price today is $1.78.
What was Adlai Nortye Ltd. - ADR stock price yesterday?
Adlai Nortye Ltd. - ADR stock price yesterday was $1.79.
What is the 50-day moving average of Adlai Nortye Ltd. - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Adlai Nortye Ltd. - ADR 50-day moving average is $1.61.
How many employess does Adlai Nortye Ltd. - ADR has?